Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by Sibo1on Jul 10, 2012 3:36pm

230 Views

Post# 20099307

RE: Bacticent™ KB

Very interesting Perpetualcoolie. It appears Kane's Aledex and Harland's Bacticent are one and the same product.

A quick Google search on Bacticent KB shows it being offered as a coating in various locations around the world. If it's as effective as claimed this should result in significant sales for Harland and royalties to Kane.

The potential market is huge. Do you have any idea of the costs involved in a coating and the subsequent royalties that may flow to Kane?

Bullboard Posts

Visionstate set to leverage success in the U.S. market